Profile
ACIU VRTX REGN VRNA ARGX ALNY
Company Name AC Immune S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $297.78M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.13K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Andrea Pfeifer Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ACIU VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
ACIU VRTX REGN VRNA ARGX ALNY
Last Close $3.1 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $3.99 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.48 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -22.31 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 109.46 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ACIU VRTX REGN VRNA ARGX ALNY
1 Month Return 6.9 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 44.19 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 81.29 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 17.42 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 14.81 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -5.2 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -53.02 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ACIU VRTX REGN VRNA ARGX ALNY
Asset Growth 26.31 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 11.42 % 1.16 % - 26.81 %
Revenue Growth 84.51 % 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year -82.49 % 73.64 % - 775.72 %
Revenue 10 Year -49.87 % 285.02 % - 2487.4 %
EBIT Growth 6.04 % 9.09 % -131.37 % 24.59 %
Net Income Growth 6.12 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 47.56 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -179.35 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -363.33 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 2.32 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 209 % - -143.33 % -107.98 %
Operating 3 Year CFG 175.36 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -15.56 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 307.6 % -100 % 40.15 % 97.08 %
EPS Growth 20.31 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 20.31 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -40.63 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -63.61 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -70.82 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 165.84 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 55.19 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 206.63 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ACIU VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -41.88 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -83.51 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -100.3 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 97.73 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -1682.11 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -1004.51 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 10.88 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 63.72 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 2.55 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.47 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.48 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 109.44 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -1070.91 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.89 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -1004.51 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -4.86 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -4.88 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -4.88 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
ACIU VRTX REGN VRNA ARGX ALNY
Revenue $0.03B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0.04B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio -129.12% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.05B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.05B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -0.51 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ACIU VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.12B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.11B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.13B $6.65B $16.08B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.23B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ACIU VRTX REGN VRNA ARGX ALNY
Net Income $-0.05B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.53
AARD Aardvark Therapeutics, Inc. Common Stock 12.71
ABCL AbCellera Biologics Inc. 3.1048
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.08
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.32
ABPWW 0.0155
ABSI Absci Corporation 2.659
ABUS Arbutus Biopharma Corporation 3.82
ABVC ABVC BioPharma, Inc. 1.73
ABVX Abivax SA American Depositary Shares 117.345
ACAD ACADIA Pharmaceuticals Inc. 23.055
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.97
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.11
ACLX Arcellx, Inc. 67.98
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.02 173.165
GWX SPDR S&P International Small Cap ETF 0.02 44.645
BIB ProShares Ultra Nasdaq Biotechnology 0.0162302 85.125
SBIO ALPS Medical Breakthroughs ETF 0.002 50.1165
BMED BlackRock Future Health ETF 0.0106 30.8983
DFAU Dimensional US Core Equity Market ETF 0.00023469 47.895
IBBQ Invesco Nasdaq Biotechnology ETF 0.022749 29.48
DFAT Dimensional U.S. Targeted Value ETF 0.0001165 66.425
DFAS Dimensional U.S. Small Cap ETF 0.00083615 75.87
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000563 41.22
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02 7.263
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02 8.6425
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0229 51.83
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02 8.59
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0229 61.74
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 35.14
DFSU Dimensional US Sustainability Core 1 ETF 0.00043928 44.25
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02 6.3375
DXUV Dimensional ETF Trust 0.00284318 63.45
Unlock